Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Return on Sales: 2011-2018

Historic Return on Sales for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -15.54%.

  • EyePoint Pharmaceuticals' Return on Sales fell 1327.00% to -15.54% in Q3 2018 from the same period last year, while for Sep 2018 it was -15.54%, marking a year-over-year decrease of 1327.00%. This contributed to the annual value of -17.96% for FY2018, which is 1551.00% down from last year.
  • According to the latest figures from Q3 2018, EyePoint Pharmaceuticals' Return on Sales is -15.54%, which was down 25.86% from -12.35% recorded in Q2 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Return on Sales peaked at 0.39% during Q3 2014, and registered a low of -16.61% during Q3 2016.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Return on Sales value was -10.80% (recorded in 2016), while the average stood at -9.30%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by 1,360bps in 2016, then surged by 1,435bps in 2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Return on Sales (Quarterly) stood at 0.37% in 2014, then tumbled by 1,112bps to -10.75% in 2015, then surged by 804bps to -2.71% in 2016, then plummeted by 1,028bps to -12.99% in 2017, then plummeted by 1,327bps to -15.54% in 2018.
  • Its Return on Sales was -15.54% in Q3 2018, compared to -12.35% in Q2 2018 and -10.69% in Q1 2018.